HopeStage
Back to all studies
Not recruitingISRCTN12746343

Efficacy and safety of the Xiaoyao pill for improving the clinical symptoms of stagnation of liver qi (chi) and spleen deficiency

Research studyAges 18+ChinaDepression
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
China

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Not recruiting
Enrollment listed in the registry
Not clearly listed
Sponsor
Beijing University of Chinese Medicine
Sponsor type
University
Study type
Other
Intervention type
Other / unclear
Locations
China
Age range
Over 18 Years
Official registry ID
ISRCTN12746343
Official title
Show the full official title

Efficacy and safety of the Xiaoyao pill for improving the clinical symptoms of stagnation of liver qi (chi) and spleen deficiency

Recruitment & locations

Not recruiting

China

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Beijing University of Chinese Medicine, a university.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as not recruiting.

Want to explore more studies?

Explore studies